Out of the Crisis #5, ANA Therapeutics: a possible COVID-19 treatment and prophylactic
Startup Lessons Learned
MAY 27, 2020
51:36) Scientific background on niclosamide, what we know about how it works to stop viral replication. (52:48) And often what we're seeing in these hydroxychloroquine studies is a big ratcheting of a typical dose. You ratchet up a drug that has known side effects. 43:26) Differences between coronaviruses and other viruses. (44:41)
68 
Let's personalize your content